The balance of signals transmitted by inhibitory LILRB3 and activating LILRA6 might therefore determine whether an immune response is initiated to the dead tumour cell, thereby to influence the wider immune response within the tumour microenvironment. The gene discussed is LILRB3; the disease is neoplasm.